|
Orchid Pharma has allotted 99,02,705 equity shares of face value Rs 10 each to eligible qualified institutional buyers at the issue price of Rs 403.93 per equity share (including a premium of Rs 393.93 per equity share) reflects a discount of Rs 21.26 (i.e. 5%) on the Floor Price of Rs 425.19 per equity share, aggregating to Rs 400 crore.
The QIP issue opened on 22 June 2023 and closed on 27 June 2023.
Pursuant to the allotment of equity shares in the Issue, the paid-up equity share capital of the Company stands increased from Rs 40,81,64,000 comprising of 4,08,16,400 equity shares to Rs 50,71,91,050 comprising of 5,07,19,105 equity shares.
|